Strategies to directly engineer red blood cells (RBCs) in vivo for drug delivery, imaging, and other applications are lacking. Here, the authors develop a strategy for in vivo metabolic tagging of RBCs and show applications in imaging and prolonged blood circulation of therapeutic agents.
- Yusheng Liu
- Yizun Wang
- Hua Wang